The independent source for health policy research, polling, and news.
March 1, 2021
In this Axios column, Drew Altman paints a more optimistic picture of the prospects for getting to herd immunity as vaccine confidence grows, but underscores the urgency of building vaccine confidence in Black and Latino communities where barriers to access and good information are obstacles to getting vaccinated.
Column Read PostFebruary 19, 2021
In this article for The Lancet, KFF’s Jennifer Kates and Lindsey Dawson, and five co-authors provide an overview of the coverage and financing landscape for HIV treatment and prevention in the U.S., discuss how the Affordable Care Act has changed the domestic health care system, examine the major programs that…
Read PostFebruary 10, 2021
In his latest Axios column, Drew Altman shows why vaccine hesitancy will naturally decrease as more and more people see their family members and friends vaccinated without adverse consequences. It’s a hopeful sign about vaccine hesitancy, and should help free up resources to focus on the remaining vaccine hesitant.
Column Read PostJanuary 27, 2021
In this Viewpoint for the Journal of the American Medical Association (JAMA), KFF’s Tricia Neuman and co-author Richard G. Frank of Harvard Medical School explain that the looming 2024 insolvency of the Medicare Hospital Insurance Trust Fund cannot be ignored for long.
Column Read PostJanuary 26, 2021
Debate about how many vaccinations are needed by when has been in the news. Drew Altman lays it out in his latest column.
Column Read PostJanuary 19, 2021
Published in the Jan. 19 edition of JAMA, this article from KFF Executive Vice President for Health Policy Larry Levitt lays out the major health policy challenges that will confront President-elect Biden and potential approaches to major reform. While a big reform debate may not be likely this year, one…
Column Read Post